2008T, Hemodialysis Delivery System Product Indicated for acute and chronic dialysis therapy.
FDA Device Recall #Z-0829-2018 — Class II — October 5, 2017
Recall Summary
| Recall Number | Z-0829-2018 |
| Classification | Class II — Moderate risk |
| Date Initiated | October 5, 2017 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Fresenius Medical Care Renal Therapies Group, LLC |
| Location | Waltham, MA |
| Product Type | Devices |
| Quantity | 15 machines |
Product Description
2008T, Hemodialysis Delivery System Product Indicated for acute and chronic dialysis therapy.
Reason for Recall
While reviewing documentation for the next software release of the 2008T, an R&D technician identified that setting the UF goal to '0' introduces a discrepancy between the UF rate displayed and the actual UF pump rate. The software anomaly is also applicable to the 2008T Machines that contained the 2.63 Bug Fix per DCAF 17-088. 2008T Upgrade kits that contained the 2.63 Bug Fix are also affected. Additionally, SW version 2.64 (in design freeze) is also impacted by this anomaly.
Distribution Pattern
US Nationwide Distribution
Lot / Code Information
2008T machines: 190766 2008T Hemodialysis System w/Bibag 190895 2008T GEN 2 Bibag without CDX 190766 = 00840861100910 (+Serial Number) 190895 = 00840861100927 (+Serial Number)ux=&Su
Other Recalls from Fresenius Medical Care Renal Therapie...
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-2151-2019 | Class II | Liberty Cycler Cassettes (a disposable cassette... | May 29, 2019 |
| Z-1699-2019 | Class III | 2008T BlueStar Machine Software v.2.72-Hemodial... | Apr 3, 2019 |
| Z-0658-2019 | Class II | Optiflux F160NR Capillary High Flux Dialyzer Si... | Nov 5, 2018 |
| Z-0517-2019 | Class III | Fresenius Granuflo Dry Acid Concentrate- 2K 2.5... | Oct 9, 2018 |
| Z-0518-2019 | Class III | Fresenius Granuflo Dry Acid Concentrate- 3K 2.... | Oct 9, 2018 |
Frequently Asked Questions
A software recall means the device's embedded software or firmware has a defect that could affect its performance or safety. Many software recalls are corrected through firmware updates that can be applied without physically replacing the device. For implantable devices, the update may be delivered wirelessly during a routine clinic visit. For external devices, the manufacturer may provide updated software files or replacement units. Contact your healthcare provider to determine whether your specific device and software version are affected and what action is recommended.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.